Literature DB >> 18799583

Human immunodeficiency virus type 1 Nef induces programmed death 1 expression through a p38 mitogen-activated protein kinase-dependent mechanism.

Karuppiah Muthumani1, Andrew Y Choo, Devon J Shedlock, Dominick J Laddy, Senthil G Sundaram, Lauren Hirao, Ling Wu, Khanh P Thieu, Christopher W Chung, Karthikbabu M Lankaraman, Pablo Tebas, Guido Silvestri, David B Weiner.   

Abstract

Chronic viral infection is characterized by the functional impairment of virus-specific T-cell responses. Recent evidence has suggested that the inhibitory receptor programmed death 1 (PD-1) is specifically upregulated on antigen-specific T cells during various chronic viral infections. Indeed, it has been reported that human immunodeficiency virus (HIV)-specific T cells express elevated levels of PD-1 and that this expression correlates with the viral load and inversely with CD4(+) T-cell counts. More importantly, antibody blockade of the PD-1/PD-L1 pathway was sufficient to both increase and stimulate virus-specific T-cell proliferation and cytokine production. However, the mechanisms that mediate HIV-induced PD-1 upregulation are not known. Here, we provide evidence that the HIV type 1 (HIV-1) accessory protein Nef can transcriptionally induce the expression of PD-1 during infection in vitro. Nef-induced PD-1 upregulation requires its proline-rich motif and the activation of the downstream kinase p38. Further, inhibition of Nef activity by p38 MAPK inhibitor effectively blocked PD-1 upregulation, suggesting that p38 MAPK activation is an important initiating event in Nef-mediated PD-1 expression in HIV-1-infected cells. These data demonstrate an important signaling event of Nef in HIV-1 pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18799583      PMCID: PMC2583658          DOI: 10.1128/JVI.00485-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity.

Authors:  J He; S Choe; R Walker; P Di Marzio; D O Morgan; N R Landau
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

2.  HIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral rebound.

Authors:  Thomas J Scriba; Hua-Tang Zhang; Helen L Brown; Annette Oxenius; Norbert Tamm; Sarah Fidler; Julie Fox; Jonathan N Weber; Paul Klenerman; Cheryl L Day; Michaela Lucas; Rodney E Phillips
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

3.  HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.

Authors:  K L Collins; B K Chen; S A Kalams; B D Walker; D Baltimore
Journal:  Nature       Date:  1998-01-22       Impact factor: 49.962

4.  RWJ 67657, a potent, orally active inhibitor of p38 mitogen-activated protein kinase.

Authors:  S A Wadsworth; D E Cavender; S A Beers; P Lalan; P H Schafer; E A Malloy; W Wu; B Fahmy; G C Olini; J E Davis; J L Pellegrino-Gensey; M P Wachter; J J Siekierka
Journal:  J Pharmacol Exp Ther       Date:  1999-11       Impact factor: 4.030

5.  Use of a drug-resistant mutant of stress-activated protein kinase 2a/p38 to validate the in vivo specificity of SB 203580.

Authors:  P A Eyers; P van den IJssel; R A Quinlan; M Goedert; P Cohen
Journal:  FEBS Lett       Date:  1999-05-21       Impact factor: 4.124

6.  Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor.

Authors:  H Nishimura; M Nose; H Hiai; N Minato; T Honjo
Journal:  Immunity       Date:  1999-08       Impact factor: 31.745

7.  Soluble Nef antigen of HIV-1 is cytotoxic for human CD4+ T cells.

Authors:  Y Fujii; K Otake; M Tashiro; A Adachi
Journal:  FEBS Lett       Date:  1996-09-09       Impact factor: 4.124

8.  Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice.

Authors:  Z Hanna; D G Kay; N Rebai; A Guimond; S Jothy; P Jolicoeur
Journal:  Cell       Date:  1998-10-16       Impact factor: 41.582

9.  In vivo pathogenesis of a human immunodeficiency virus type 1 reporter virus.

Authors:  B D Jamieson; J A Zack
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

10.  Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4.

Authors:  K Saksela; G Cheng; D Baltimore
Journal:  EMBO J       Date:  1995-02-01       Impact factor: 11.598

View more
  37 in total

Review 1.  Signaling through the P38 and ERK pathways: a common link between HIV replication and the immune response.

Authors:  Robert L Furler; Christel H Uittenbogaart
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

2.  p38 Mitogen-activated protein kinase/signal transducer and activator of transcription-3 pathway signaling regulates expression of inhibitory molecules in T cells activated by HIV-1-exposed dendritic cells.

Authors:  Karlhans Fru Che; Esaki Muthu Shankar; Sundaram Muthu; Sasan Zandi; Mikael Sigvardsson; Jorma Hinkula; Davorka Messmer; Marie Larsson
Journal:  Mol Med       Date:  2012-10-24       Impact factor: 6.354

3.  Optimized and enhanced DNA plasmid vector based in vivo construction of a neutralizing anti-HIV-1 envelope glycoprotein Fab.

Authors:  Kar Muthumani; Seleeke Flingai; Megan Wise; Colleen Tingey; Kenneth E Ugen; David B Weiner
Journal:  Hum Vaccin Immunother       Date:  2013-09-17       Impact factor: 3.452

Review 4.  Animal models for viral infection and cell exhaustion.

Authors:  Colleen S McGary; Guido Silvestri; Mirko Paiardini
Journal:  Curr Opin HIV AIDS       Date:  2014-09       Impact factor: 4.283

5.  Target of HIV-1 Envelope Glycoprotein gp120-Induced Hippocampal Neuron Damage: Role of Voltage-Gated K(+) Channel Kv2.1.

Authors:  Qing Zhu; Xu Song; Jing Zhou; Yixin Wang; Jianxun Xia; Wenyi Qian; Jingying Zhu; Rong Gao; Jun Wang; Hang Xiao
Journal:  Viral Immunol       Date:  2015-09-22       Impact factor: 2.257

6.  HIV-mediated phosphatidylinositol 3-kinase/serine-threonine kinase activation in APCs leads to programmed death-1 ligand upregulation and suppression of HIV-specific CD8 T cells.

Authors:  Karuppiah Muthumani; Devon J Shedlock; Daniel K Choo; Paolo Fagone; Omkar U Kawalekar; Jonathan Goodman; Chaoran B Bian; Aarti A Ramanathan; Parikh Atman; Pablo Tebas; Michael A Chattergoon; Andrew Y Choo; David B Weiner
Journal:  J Immunol       Date:  2011-08-19       Impact factor: 5.422

7.  Down-regulation of HIV-1 infection by inhibition of the MAPK signaling pathway.

Authors:  Jian Gong; Xi-hui Shen; Chao Chen; Hui Qiu; Rong-ge Yang
Journal:  Virol Sin       Date:  2011-04-07       Impact factor: 4.327

8.  B and T lymphocyte attenuator down-regulation by HIV-1 depends on type I interferon and contributes to T-cell hyperactivation.

Authors:  Zheng Zhang; Xiangsheng Xu; Jiyun Lu; Shuye Zhang; Lanlan Gu; Junliang Fu; Lei Jin; Haiying Li; Min Zhao; Jiyuan Zhang; Hao Wu; Lishan Su; Yang-Xin Fu; Fu-Sheng Wang
Journal:  J Infect Dis       Date:  2011-06-01       Impact factor: 5.226

Review 9.  PD-1 and CTLA-4 inhibitory cosignaling pathways in HIV infection and the potential for therapeutic intervention.

Authors:  Daniel E Kaufmann; Bruce D Walker
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

10.  HIV-1 Nef and T-cell activation: a history of contradictions.

Authors:  Tristan J Markle; Mwimanzi Philip; Mark A Brockman
Journal:  Future Virol       Date:  2013-04-01       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.